Insulin-like growth factor I in essential hypertension

被引：25
|
作者：
Díez, J
Madias, NE
Egido, J
Rodicio, JL
Lamas, S
Zucchelli, P
Lopez-Novoa, JM
Caramelo, C
Bosch, R
机构：
[1] Univ Navarra, Sch Med, Vasc Pathophysiol Unit, Fac Med, E-31080 Pamplona, Spain
[2] Univ Zaragoza, Sch Med, E-50009 Zaragoza, Spain
[3] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA
[4] Fdn Jimenez Diaz, Div Nephrol, Madrid, Spain
[5] Univ Autonoma Madrid, Sch Med, E-28049 Madrid, Spain
[6] 12 Octubre Univ Hosp, Div Nephrol, Madrid, Spain
[7] Univ Complutense, Sch Med, E-28040 Madrid, Spain
[8] Gregorio Maranon Univ Hosp, Dept Nephrol, Madrid, Spain
[9] High Council Sci Res, Biol Res Ctr, Madrid, Spain
[10] Policlin S Orsola, Malpighi Dept Nephrol, Bologna, Italy
[11] Univ Salamanca, Sch Med, Dept Physiol, E-37008 Salamanca, Spain
[12] Univ Alcala de Henares, Sch Med, Dept Physiol, Alcala De Henares, Spain
来源：
KIDNEY INTERNATIONAL | 1999年 / 55卷 / 02期
关键词：
growth hormone; left-ventricular hypertrophy; insulin resistance; nitric oxide; ACE inhibitors; microalbuminuria;
D O I：
10.1046/j.1523-1755.1999.00300.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：744 / 759
页数：16
相关论文
共 50 条
  • [1] Impaired insulin-like growth factor I vasorelaxant effects in hypertension
    Vecchione, C
    Colella, S
    Fratta, L
    Gentile, MT
    Selvetella, G
    Frati, G
    Trimarco, B
    Lembo, G
    HYPERTENSION, 2001, 37 (06) : 1480 - 1485
  • [2] Cardiac insulin-like growth factor I and growth hormone receptor expression in renal hypertension
    Guron, G
    Friberg, P
    Wickman, A
    Brantsing, C
    Gabrielsson, B
    Isgaard, J
    HYPERTENSION, 1996, 27 (03) : 636 - 642
  • [3] Insulin-Like Growth Factor I, Insulin-like Growth factor Binding Protein 3, and Atrial Fibrillation in the Elderly
    Duron, Emmanuelle
    Vidal, Jean-Sebastien
    Funalot, Benoit
    Brunel, Nadege
    Viollet, Cecile
    Seux, Marie-Laure
    Treluyer, Jean-Marc
    Epelbaum, Jacques
    Le Bouc, Yves
    Hanon, Olivier
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2014, 69 (08): : 1025 - 1032
  • [4] Insulin-like growth factor-I deficiency
    Camacho-Hübner, C
    Savage, M
    HORMONE RESEARCH, 2001, 55 : 17 - 20
  • [5] Acromegaly and serum insulin-like growth factor I
    Thorner, MO
    HORMONE RESEARCH, 2004, 62 : 34 - 36
  • [6] Insulin-like growth factor-I and the liver
    Bonefeld, Karen
    Moller, Soren
    LIVER INTERNATIONAL, 2011, 31 (07) : 911 - 919
  • [7] Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension:: effects of angiotensin converting enzyme inhibition
    Laviades, C
    Gil, MJ
    Monreal, I
    González, A
    Díez, J
    JOURNAL OF HYPERTENSION, 1998, 16 (06) : 863 - 870
  • [8] Effects of octreotide on serum insulin-like growth factor I and insulin-like growth factor binding proteins in patients with cirrhosis
    Ottesen, LH
    Frystyk, J
    Kiszka-Kanowitz, M
    Gronbæk, H
    Bendtsen, F
    Flyvbjerg, A
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2002, 62 (01) : 39 - 47
  • [9] The insulin-like growth factor system in kidney disease and hypertension
    Bach, Leon A.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (01) : 86 - 91
  • [10] Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity
    Lau, K. -H. William
    Baylink, David J.
    Zhou, Xiao-Dong
    Rodriguez, Denise
    Bonewald, Lynda F.
    Li, Zihui
    Ruffoni, Davide
    Mueller, Ralph
    Kesavan, Chandrasekhar
    Sheng, Matilda H. -C.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2013, 305 (02): : E271 - E281
12345